Orphan Drug Amendments
Executive Summary
House passed Rep. Waxman's (D-Calif.) Orphan Drug Amendments on March 22 by a 409-1 vote. The legislation, which essentially reauthorizes the Orphan Drug Act and expands research funding ("The Pink Sheet" March 7, p. 10), was adopted under suspension of the rules. The House bill was referred directly to the Senate floor on March 25 and held at the desk by Sen. Kennedy (D-Mass.). It could be considered by the Senate in the week of March 28.